Int J Angiol 2011; 20(2): 073-080
DOI: 10.1055/s-0031-1279685
REVIEW ARTICLE

© Thieme Medical Publishers

Current Status of Lymphatic Reconstructive Surgery for Chronic Lymphedema: It Is Still an Uphill Battle!

B.B. Lee1 , J. Laredo1 , R. Neville1
  • 1Division of Vascular Surgery, Department of Surgery, George Washington University School of Medicine, Washington, D.C
Further Information

Publication History

Publication Date:
03 June 2011 (online)

Preview

ABSTRACT

The goal of reconstructive lymphatic surgery is to restore normal lymphatic function to “cure” permanently the lymphedematous limb in patients with lymphedema. In reality, reconstructive surgery remains an adjunctive treatment at best, with its current indication being refractory lymphedema in patients treated with complex decongestive therapy (CDT) alone. The role of reconstructive lymphatic surgery remains controversial and is far from being accepted as standard independent therapy because of multiple reasons. However, reconstructive surgery appears to be most effective in controlling the progression of lymphedema during the early stages when the paralyzed lymph vessels are still able to function and recover. Our experience in reconstructive surgery has shown that improved long-term results are dependent on prolonged patient compliance with maintenance CDT and the prevention and treatment of infection. To better understand the role of reconstructive surgery in the management of chronic lymphedema, well-constructed clinical trials based on well-organized multicenter studies with similar protocols are mandated. For the future, it remains the only possible treatment method capable of providing a cure.

REFERENCES

Byung-Boong LeeM.D. Ph.D. F.A.C.S. 

Clinical Professor of Surgery, Director, Center for Vein, Lymphatics and Vascular Malformations, Division of Vascular Surgery, Department of Surgery

George Washington University Medical Center, 22nd and I Street, NW, 6th Floor, Washington, DC 20037

Email: bblee38@comcast.net

Email: bblee38@gmail.com